Corporate insider profile
Steven Gannon Insider Trades
Latest reported as Director of Xenon Pharmaceuticals Inc. (XENE).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$640,550.00
- Latest transaction
- Aug 11, 2026
Affiliated corporations
Reported company relationships
Transaction history
